Three pharmaceutical industry veterans today announced the creation of CELYSTRA Pharma, a new Quebec-based biopharmaceutical company specializing in the introduction of innovative treatments to Canada ...
Zacks Investment Research on MSN
Bristol Myers Squibb Company (BMY) is attracting investor attention: Here is what you should know
Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Zenas BioPharma (ZBIO) added ~8% in the premarket on Thursday after the chief executive of the clinical-stage biotech ...
Proven immunology-focused executive and physician-scientist who has led companies from inception to IPO, driven multiple ...
ESTERO, FL / ACCESS Newswire / April 27, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the ...
Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Small Cap Growth ...
Pharmaceutical companies may face earnings pressure, but long-term fundamentals and opportunities remain. Find out what advisors and investors should know about the risks, potential price concessions, ...
However, when several insiders are buying, like in the case of Aytu BioPharma, Inc. (NASDAQ:AYTU), it sends a favourable ...
US drug-maker Avalyn Pharma has hired Adam Golden as general counsel as the company moves ahead with its plans to go public.
Theravance Biopharma, Inc. (NASDAQ:TBPH) is one of the most undervalued biotech stocks to buy right now. B. Riley lifted the ...
Sutro Biopharma underwent major restructuring, including management changes and layoffs. Read why I rate STRO stock a Strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results